spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Allegra 

 HSMN NewsFeed - 9 Feb 2022
ARS Pharmaceuticals Expands Executive Leadership Team with Addition of Pharmaceutical Commercialization Veterans
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Jul 2015
AMRI Acquires Gadea Pharmaceutical Group
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 24 Mar 2014
AMRI to Acquire Cedarburg Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Mar 2012
VIVUS Announced Expansion of Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Jan 2011
U.S. FDA Approves Number One U.S.-Prescribed Allergy Treatment Allegra for Over-The-Counter Use
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Nov 2010
Euthymics Bioscience, Inc. Names Biotech Executive Timothy J. Barberich to Board of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 11 Mar 2010
sanofi-aventis Successfully Completes the Acquisition of Chattem, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Apr 2009
Phase III C-08 Study of Avastin in Early-Stage Colon Cancer Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 20 Jan 2009
FDA Issues Complete Response Letter to SCOLR Pharma's Abbreviated New Drug Application for CDT(R) 12-Hour Pseudoephedrine
Biopharmaceuticals Drug Delivery FDA
 HSMN NewsFeed - 20 Nov 2008
Teva Provides Update on Generic Pulmicort Respules® Launch
Biopharmaceuticals Generics
 HSMN NewsFeed - 20 Oct 2008
Genentech Announces Phase III Study of Avastin Plus Chemotherapy in Adjuvant Colon Cancer Will Continue
Biopharmaceuticals Oncology
 HSMN NewsFeed - 22 Sep 2008
Teva Introduces Nicardipine HCl Injection in the United States; First Alternative to Cardene(R) I.V.
Biopharmaceuticals Generics Cardiology
 HSMN NewsFeed - 18 Sep 2008
Laquinimod Demonstrated Significant and Sustained Impact on Multiple Sclerosis Disease Activity
Biopharmaceuticals Neurology
 HSMN NewsFeed - 18 Sep 2008
Longest Prospective Study in MS Confirmed Robust Clinical Benefits and Safety of COPAXONE(R)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Sep 2008
Teva Receives EU Marketing Authorization for TevaGrastim(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 23 Jul 2008
Teva Completes Acquisition of Bentley Pharmaceuticals
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 18 Jul 2008
Teva to Acquire Barr
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jul 2008
Teva Enrolls Patients for a Second Large Global Phase III Trial of Oral Laquinimod
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Jul 2008
Teva Comments on Paragraph IV Filing for COPAXONE(R); Intends to File Lawsuit against Generic Filer for Patent Infringement
Biopharmaceuticals Generics Neurology FDA Litigation
 HSMN NewsFeed - 1 Jul 2008
Teva Provides Update on Generic Seroquel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Jun 2008
Teva Announces Tentative Approval of Generic Diovan(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 May 2008
Teva Announces Launch of Generic Wellbutrin XL(R) Tablets, 150 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 30 Apr 2008
Teva Announces Global In-Market First Quarter Sales of Copaxone(R) Increased 35% to $542 Million
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Apr 2008
Teva Announces Approval of Generic Flolan(R) for Injection
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 Apr 2008
Teva Announces Tentative Approval of Generic Maxalt(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Apr 2008
COPAXONE(R) Significantly Reduced Annual Relapse Rates and Stabilized Disease Progression in Relapsing Remitting Multiple Sclerosis Patients Failing Interferon Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 31 Mar 2008
Teva Provides Update on Generic Prevacid(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 Mar 2008
Teva to Acquire Bentley Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Mar 2008
Teva Provides Update on Generic Aricept(R) Litigation
Biopharmaceuticals Generics Litigation Neurology
 HSMN NewsFeed - 13 Mar 2008
Teva Provides Update on Glatiramer Acetate 40mg for Amyotrophic Lateral Sclerosis (ALS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Mar 2008
Sciele Pharma Acquires Twinject(R) Epinephrine Auto-Injector from Verus Pharmaceuticals
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 29 Feb 2008
Teva Provides Update on Generic Actonel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 28 Feb 2008
Teva Announces Approval of Generic Camptosar(R)
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 25 Feb 2008
Sciele Expands Alliance with Sanofi-Aventis to Market Allegra(R) (Fexofenadine HCL) Orally Disintegrating Tablets (ODT) and Allegra(R) Oral Suspension (OS) in the U.S.
Biopharmaceuticals
 HSMN NewsFeed - 25 Feb 2008
Teva Announces Two Court Decisions to Revoke MSD's European Patent on Generic Fosamax(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Feb 2008
Teva Announces Approval of Generic Fosamax(R) Tablets, 5 mg, 10 mg, 35 mg, 40 mg and 70 mg
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 1 Feb 2008
Teva Provides Update on Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 31 Jan 2008
Teva Announces Tentative Approval of Generic Flomax(R) Capsules
Biopharmaceuticals Urology Generics FDA
 HSMN NewsFeed - 29 Jan 2008
Teva Announces Wyeth Voids Standstill Agreement on Generic Protonix(R)
Biopharmaceuticals Generics
 HSMN NewsFeed - 23 Jan 2008
Teva Announces Tentative Approval of Generic Prevacid(R) Delayed-Release Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 Jan 2008
Teva to Acquire CoGenesys
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 16 Jan 2008
Teva Specialty Pharmaceuticals and UCB Announce U.S. Respiratory Collaboration Agreement
Biopharmaceuticals
 HSMN NewsFeed - 14 Jan 2008
Teva Announces Tentative Approval of Generic Aricept(R) Tablets
Biopharmaceuticals Generics FDA Neurology
 HSMN NewsFeed - 14 Jan 2008
Teva to Explore Strategic Alternatives for its Animal Health Business
Biopharmaceuticals
 HSMN NewsFeed - 10 Jan 2008
Teva Announces Departure of North American CEO William S. Marth to Become CEO of Teva North America
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Jan 2008
Teva Announces Approval of Generic Kytril(R) Injection and Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 2 Jan 2008
Teva Announces Approval of Generic DuoNeb
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Dec 2007
Teva Announces Launch of Generic Protonix(R) Tablets, 20 mg and 40 mg
Biopharmaceuticals Generics
 HSMN NewsFeed - 12 Dec 2007
Teva Announces Approval of Generic Trileptal(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Dec 2007
Early Treatment with COPAXONE(R) Demonstrated Robust Protection against Progression to Clinically Definite Multiple Sclerosis in the PreCISe Study
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Nov 2007
Teva Announces Tentative Approval of Generic Requip(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 6 Nov 2007
First Patient Undergoes Expanded Cord Blood Transplant in the ExCell Registration Study of StemEx(R) for Leukemia and Lymphoma
Biopharmaceuticals Oncology
 HSMN NewsFeed - 30 Oct 2007
Teva Announces Planned Retirement of CFO Dan Suesskind in Mid-2008
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Oct 2007
New Long-Term Analysis of Clinical Treatment Outcomes Demonstrated COPAXONE(R) is More Cost Effective Than Tysabri(R) for Treatment of Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 25 Oct 2007
Study Showed Patients Using COPAXONE(R) Had Significantly Lower Risk of Relapse and Lower Medical Costs Compared to Patients Using Rebif(R) in Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 23 Oct 2007
COPAXONE(R) Significantly Decreases Disease Activity in Patients Who Switched from Interferon Beta (IFNb) Due to Development of Neutralizing Antibodies (NAbs)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Oct 2007
Adenoscan(R) Patent Lawsuits Settled
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2007
Long-Term Study Shows COPAXONE(R) Significantly Slows Progression of Disability and Reduces Relapse Rates in Patients with Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Oct 2007
Teva Announces Approval of Generic Actonel(R)
Biopharmaceuticals FDA Generics
 HSMN NewsFeed - 5 Oct 2007
Teva Announces Tentative Approval of Generic Valtrex(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Sep 2007
Teva Announces Settlement of Generic Avandia(R), Avandamet(R), and Avandaryl(R) Litigation with GlaxoSmithKline
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 19 Sep 2007
Teva Provides Update on Edratide for Systemic Lupus Erythematosus
Biopharmaceuticals
 HSMN NewsFeed - 19 Sep 2007
Teva Receives Positive Feedback on Second AOK Tender in Germany
Biopharmaceuticals
 HSMN NewsFeed - 16 Sep 2007
Teva Announces Appointment of Isaac Abravanel as Corporate Vice President, Human Resources
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2007
Teva Provides Update on Generic Famvir(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Sep 2007
Teva Announces Launch of Generic Famvir(R) Tablets
Biopharmaceuticals Generics
 HSMN NewsFeed - 6 Sep 2007
Teva Receives Favorable Court Decision Regarding Generic Protonix(R) Tablets; Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 6 Sep 2007
Teva Announces Approval and Shipment of Generic Coreg(R) Tablets
Biopharmaceuticals Cardiology Generics FDA
 HSMN NewsFeed - 5 Sep 2007
Teva Receives Favorable Court Decision Regarding Generic Famvir(R) Tablets; Novartis' Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 24 Aug 2007
Teva Announces Approval of Generic Famvir(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Aug 2007
Teva Announces Tentative Approval of Sildenafil Citrate Tablets, 20 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 10 Aug 2007
Teva Announces Approval of Epirubicin Hydrochloride Injection
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 2 Aug 2007
Teva Announces Approval of Generic Protonix(R) Delayed Release Tablets, 20 mg and 40 mg
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 29 Jun 2007
Teva Announces Approval of Amlodipine Besylate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 28 Jun 2007
Teva Announces Tentative Approval of Famciclovir Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 26 Jun 2007
Teva Announces Approval of Ondansetron HCl Tablets and Ondansetron Orally Disintegrating Tablets USP
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jun 2007
Sciele Pharma Completes Acquisition of Alliant Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 11 Jun 2007
Teva Receives Favorable Court Decision Regarding Generic Lotrel(R); Novartis' Motion for Preliminary Injunction Denied
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 8 Jun 2007
International Movement Disorder Specialists Receive New Information About the Use of Once-Daily AZILECT(R) in the Treatment of Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 Jun 2007
Teva and Active Biotech to Initiate Pivotal Phase III Trial Program of Oral Laquinimod for Relapsing Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 6 Jun 2007
COPAXONE(R) Pre-Filled Syringe Can Now Be Stored for up to One Month at Room Temperature
Biopharmaceuticals FDA Neurology
 HSMN NewsFeed - 21 May 2007
Teva Provides Update on Generic Lotrel(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 May 2007
Teva Provides Update on Generic Lotrel(R)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 May 2007
Ranbaxy Receives Tentative FDA Approval for Fexofenadine Hydrochloride Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 13 May 2007
Teva Comments About the Acquisition of Merck KGaA Generic Business
Biopharmaceuticals Generics Mergers & Acquisitions
 HSMN NewsFeed - 10 May 2007
Teva Announces Approval and Shipment of Generic Omnicef(R) Capsules and POS
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 May 2007
Teva Announces Tentative Approval of Generic Gemzar(R) for Injection
Biopharmaceuticals Generics Oncology FDA
 HSMN NewsFeed - 4 May 2007
Treatment with COPAXONE(R) Plus Minocycline Showed Substantial Reduction of Disease Activity in Patients with Active Relapsing-Remitting Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 4 May 2007
COPAXONE(R) Treatment over Two Years after Short Term Induction with Mitoxantrone Provided Sustained Benefits to Active Relapsing-Remitting Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 1 May 2007
Laquinimod, a Novel Oral Compound, Showed Significant Reduction in Disease Activity in Patients with Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 24 Apr 2007
Sciele Pharma to Acquire Alliant Pharmaceuticals, a Pediatric Specialty Pharmaceutical Company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Apr 2007
Data Published in Neurology Showed That Higher Dose of COPAXONE(R) Increased Efficacy in Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Apr 2007
First Pharmacoeconomic Analysis with Long-Term Data Showed COPAXONE(R) Was More Cost-Effective Than Interferon Beta Therapies for Treatment of Relapsing-Remitting Multiple Sclerosis (RRMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 21 Mar 2007
Teva Provides Update on Generic Celebrex(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 9 Mar 2007
Teva Receives First U.S. Approval for Generic Uniretic(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 8 Mar 2007
Teva Receives Approval for Generic Dostinex(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 5 Mar 2007
Teva Announces Agreement with Biovail and Anchen Regarding Generic Wellbutrin XL
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 1 Mar 2007
Teva Announces Approval of Alprazolam ER Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Feb 2007
Post-Hoc Data Analyses Published in Annals of Neurology Found COPAXONE(R) Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS)
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Feb 2007
Teva Announces Approval of Rabeprazole Sodium Delayed-Release Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 11 Feb 2007
Shlomo Yanai Will Assume the Role of Teva's President& CEO on March 1st, 2007
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2007
Teva Receives Approval for Generic Focalin(TM) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 24 Jan 2007
Teva Files Patent Infringement Complaints Regarding Sertraline Hydrochloride
Biopharmaceuticals Litigation
 HSMN NewsFeed - 4 Jan 2007
Avalon Pharmaceuticals Names Clinical Advisory Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Dec 2006
Largest Disease Modification Trial for Parkinson's Disease Completes Enrollment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 11 Dec 2006
Alliant Pharmaceuticals Signs Co-Promotion Agreement With sanofi-aventis for Allegra(R) (fexofenadine hydrochloride) Oral Suspension
Biopharmaceuticals
 HSMN NewsFeed - 29 Nov 2006
Teva Announces Tentative Approval of Sumatriptan Succinate Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 21 Nov 2006
Teva Announces Agreement with Pfizer Regarding Idarubicin, Azithromycin, and Epirubicin
Biopharmaceuticals Litigation
 HSMN NewsFeed - 14 Nov 2006
Court of Appeals Affirms Teva's Generic Zocor(R) Exclusivity
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 18 Oct 2006
FDA Approves Allegra(R) (fexofenadine hydrochloride) Oral Suspension for Treatment of Seasonal Allergy Symptoms and Chronic Idiopathic Urticaria
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Oct 2006
TEVA Announces Planned Retirement of President & CEO in 2007
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Oct 2006
Teva Announces OxyContin(R) Litigation Dismissed; Settlement with Purdue Finalized
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Oct 2006
Teva Announces Tentative Approval for Generic Risperdal(R) Oral Solution
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 3 Oct 2006
Long-Term Data Demonstrated Significantly Better Patient Adherence to COPAXONE(R) versus Interferons in Multiple Sclerosis Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 2 Oct 2006
COPAXONE(R) Showed Sustained Benefit on Slowing Brain Tissue Damage in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Very Active Multiple Sclerosis Patients Benefited from COPAXONE(R) Treatment Following Short-Term Induction with Mitoxantrone
Biopharmaceuticals Neurology
 HSMN NewsFeed - 29 Sep 2006
Study Showed Significant and Sustained Efficacy Of COPAXONE(R) Alone Following Short-Term Combination Therapy With IV Steroids in Multiple Sclerosis Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Sep 2006
New Data Confirmed Antibodies to COPAXONE(R) do not Impact Its Established and Sustained Long-Term Efficacy in Multiple Sclerosis
Biopharmaceuticals Neurology
 HSMN NewsFeed - 27 Sep 2006
Avalon Pharmaceuticals Appoints David D. Muth to Executive Vice President, Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Sep 2006
Teva Pharmaceutical Industries Ltd. and Protalix Biotherapeutics Ltd. Announce a Collaboration Agreement for the Development of Two Biopharmaceuticals, Based on Protalix's Recombinant Plant Cell Expression Technology
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Jul 2006
Teva Announces Final Approval of Meloxicam Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Teva Announces Tentative Approval of Generic Lotrel(R) Capsules
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 12 Jul 2006
Teva Will Be Sole Promoter of AZILECT(R) for Parkinson's Disease in the United States
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Jun 2006
Teva Receives FDA Approval for Generic Zoloft(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 27 Jun 2006
Teva Provides Generic Biaxin(R) XL Update
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 23 Jun 2006
Teva Receives First U.S. Approval of Generic Zocor(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 23 Jun 2006
Teva Announces Novartis' Sandoz Unit Seeks to Delay First FDA Approval of Generic Zocor(R)
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 22 Jun 2006
Court of Appeals Rules in Favor of Teva on Biaxin(R) XL Preliminary Injunction
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 31 May 2006
COPAXONE(R) Reduced Relapses and Stabilized Disability as Measured by Expanded Disability Status Scale, When Avonex(R) Failed
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 May 2006
Teva Announces Tentative Approval for Generic Cozaar(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 May 2006
Teva Announces Tentative Approval of Simvastatin Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 22 May 2006
Teva Announces Approval of Generic Lexapro(R) Tablets
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 17 May 2006
AZILECT(R) FDA Approval Brings New Hope to People Living With Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 17 May 2006
Teva Announces FDA Grants Approval of AZILECT(R) (Rasagiline) for Parkinson's Disease
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 8 May 2006
Long-Term Copaxone(R) Study Showed 92% of Multiple Sclerosis Patients Were Still Walking Unaided After a Mean of 10 Years on Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 7 May 2006
Teva Announces Approval of Polyethylene Glycol 3350 NF for Oral Solution
Biopharmaceuticals Generics FDA
Return to NewsFeed  

 Additional items found! 69

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 69 additional stories matching:
Allegra
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!